Say Goodbye to Your Smartphone

From Legacy Research | Ad

According to Microsoft engineer Alex Kipman, “Smartphones are yesterday's news. The phone is already dead. People just haven't realized.”

And it’s all thanks to the device inside this black box…

Click here to see it in action.

GALT Insider Trading (Galectin Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 39.40%

Insider Buying (Last 12 Months): $76,270.00

Insider Selling (Last 12 Months): $404,675.00

Galectin Therapeutics Insider Trading History Chart

Galectin Therapeutics Share Price & Price History

^$2.01

▲ +0.08 (4.15%)

As of 01/19/2022 01:00 AM ET

Days: 30 | 90 | 365

Buy Live Nation (LYV) Immediately

From Stansberry | Ad

Wall Street legend who helped create America’s stock-rating system says this stock could soon be rated a “Strong Buy” at every bank in New York City and Boston. “It’s all part of the biggest prediction of my 50-year career on Wall Street,” he says. “A massive and surprising new transition that could determine the next group of millionaires.”

Click here to learn more.

Galectin Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/19/2022	Kevin D. Freeman	Director	Buy	5,000	$1.96	$9,800.00
1/14/2022	Richard A Jr. Zordani	Director	Buy	5,000	$2.02	$10,100.00
1/11/2022	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.10	$21,000.00
12/6/2021	Kevin D. Freeman	Director	Buy	5,000	$2.34	$11,700.00
12/2/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.37	$23,700.00
11/1/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.19	$31,900.00
10/29/2021	Kevin D. Freeman	Director	Buy	2,000	$3.17	$6,340.00
10/21/2021	Kevin D. Freeman	Director	Buy	2,000	$3.19	$6,380.00
10/19/2021	Kevin D. Freeman	Director	Buy	3,000	$3.37	$10,110.00
10/15/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.37	$33,700.00
10/4/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.62	$36,200.00
9/23/2021	Kevin D. Freeman	Director	Buy	3,000	$3.88	$11,640.00
9/1/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.91	$39,100.00
8/2/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.25	$32,500.00
7/9/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.54	$35,400.00
5/3/2021	Fund L.P. 10X	Major Shareholder	Sell	27,500	$3.97	$109,175.00
4/5/2021	Kevin D. Freeman	Director	Buy	5,000	$2.04	$10,200.00	23,469
4/1/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.16	$21,600.00
2/2/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.04	$20,400.00
1/11/2021	Gilbert F Amelio	Director	Sell	60,000	$2.17	$130,200.00	60,614
10/13/2020	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.97	$29,700.00
9/4/2020	Kevin D. Freeman	Director	Buy	5,000	$2.57	$12,850.00	23,469
3/19/2020	Kevin D. Freeman	Director	Buy	6,000	$1.69	$10,140.00
1/17/2020	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.97	$29,700.00
11/15/2019	Kevin D. Freeman	Director	Buy	3,000	$3.36	$10,080.00	23,469
10/10/2019	Fund L.P. 10X	Major Shareholder	Sell	17,000	$3.73	$63,410.00
9/6/2019	Kevin D. Freeman	Director	Buy	1,290	$3.71	$4,785.90	23,469
5/31/2019	Jack W Callicutt	CFO	Buy	2,354	$4.28	$10,075.12	3,614
5/31/2019	Richard E Uihlein	Director	Buy	4,680,606	$4.28	$20,032,993.68	3,128,489
4/9/2019	Richard E Uihlein	Director	Buy	20,700	$4.82	$99,774.00	2,628,489
4/5/2019	Kevin D. Freeman	Director	Buy	500	$4.73	$2,365.00	22,043
2/22/2019	Marc Rubin	Director	Sell	51,185	$6.02	$308,133.70	13,581
2/8/2019	Kevin D. Freeman	Director	Buy	1,500	$4.29	$6,435.00	22,043
1/31/2019	Gilbert F Amelio	Director	Sell	30,000	$5.00	$150,000.00
1/29/2019	Richard E Uihlein	Director	Buy	51,500	$4.87	$250,805.00	2,538,289

Insider Selling at Galectin Therapeutics?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Galectin Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Galectin Therapeutics (NASDAQ:GALT)

12.28% of Galectin Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Galectin Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2021	Squarepoint Ops LLC	39,191	$0.15M	0.0%	-30.2%	0.066%
11/16/2021	Millennium Management LLC	350,336	$1.36M	0.0%	-38.4%	0.591%
11/15/2021	Capstone Investment Advisors LLC	42,260	$0.16M	0.0%	N/A	0.071%
11/15/2021	Morgan Stanley	49,968	$0.20M	0.0%	+22.4%	0.084%
11/12/2021	Ameritas Investment Company LLC	44,232	$0.17M	0.0%	+12.7%	0.075%
11/12/2021	Centaurus Financial Inc.	22,614	$88K	0.0%	+44.8%	0.038%
11/12/2021	Geode Capital Management LLC	540,866	$2.10M	0.0%	+32.2%	0.912%
11/10/2021	Goldman Sachs Group Inc.	14,717	$57K	0.0%	-19.0%	0.025%
11/10/2021	Buckingham Strategic Wealth LLC	10,734	$42K	0.0%	N/A	0.018%
11/9/2021	BlackRock Inc.	787,582	$3.06M	0.0%	-0.8%	1.328%
11/8/2021	Keybank National Association OH	100,000	$0.39M	0.0%	N/A	0.169%
11/4/2021	QCI Asset Management Inc. NY	55,000	$0.21M	0.0%	+120.0%	0.093%
11/2/2021	Raymond James & Associates	13,096	$51K	0.0%	N/A	0.022%
11/2/2021	Benjamin F. Edwards & Company Inc.	23,600	$92K	0.0%	-32.0%	0.040%
11/2/2021	Cambridge Investment Research Advisors Inc.	164,498	$0.64M	0.0%	-2.3%	0.277%
10/29/2021	Commonwealth Equity Services LLC	11,902	$46K	0.0%	N/A	0.020%
10/8/2021	Wedbush Securities Inc.	30,998	$0.12M	0.0%	+72.2%	0.052%
9/3/2021	Parametric Portfolio Associates LLC	56,047	$0.18M	0.0%	+62.9%	0.096%
8/25/2021	Marshall Wace LLP	47,509	$0.15M	0.0%	N/A	0.082%
8/23/2021	Morgan Stanley	40,810	$0.13M	0.0%	+54.8%	0.070%
8/17/2021	Wells Fargo & Company MN	12,040	$39K	0.0%	-40.8%	0.021%
8/17/2021	Millennium Management LLC	568,690	$1.82M	0.0%	N/A	0.979%
8/17/2021	Boothbay Fund Management LLC	10,965	$35K	0.0%	N/A	0.019%
8/16/2021	Squarepoint Ops LLC	56,128	$0.18M	0.0%	N/A	0.097%
8/16/2021	Ameritas Investment Company LLC	39,232	$0.13M	0.0%	N/A	0.068%
8/16/2021	Bank of America Corp DE	12,217	$40K	0.0%	-74.3%	0.021%
8/16/2021	LMR Partners LLP	19,285	$62K	0.0%	N/A	0.033%
8/16/2021	Morgan Stanley	40,810	$0.13M	0.0%	+54.8%	0.070%
8/16/2021	Charles Schwab Investment Management Inc.	17,413	$56K	0.0%	-77.5%	0.030%
8/16/2021	State Street Corp	158,759	$0.51M	0.0%	-74.2%	0.273%
8/16/2021	Tibra Equities Europe Ltd	98,700	$0.32M	0.1%	N/A	0.170%
8/16/2021	Marshall Wace LLP	47,509	$0.15M	0.0%	N/A	0.082%
8/13/2021	Renaissance Technologies LLC	370,199	$1.19M	0.0%	+20.6%	0.637%
8/13/2021	Northern Trust Corp	96,270	$0.31M	0.0%	-77.1%	0.166%
8/13/2021	LPL Financial LLC	52,034	$0.17M	0.0%	+219.5%	0.090%
8/13/2021	Geode Capital Management LLC	409,013	$1.31M	0.0%	-36.7%	0.704%
8/13/2021	Vanguard Group Inc.	1,953,419	$6.25M	0.0%	+1.1%	3.362%
8/12/2021	XTX Topco Ltd	12,419	$40K	0.0%	N/A	0.021%
8/12/2021	Ergoteles LLC	139,181	$0.45M	0.0%	N/A	0.240%
8/11/2021	Bank of New York Mellon Corp	23,080	$74K	0.0%	-76.9%	0.040%
8/11/2021	BlackRock Inc.	793,934	$2.54M	0.0%	-69.7%	1.367%
8/11/2021	Susquehanna Fundamental Investments LLC	15,600	$50K	0.0%	N/A	0.027%
8/10/2021	Cambridge Investment Research Advisors Inc.	168,316	$0.54M	0.0%	N/A	0.290%
8/10/2021	Rockefeller Capital Management L.P.	10,386	$33K	0.0%	+419.3%	0.018%
8/2/2021	Advisor Group Holdings Inc.	1,273,157	$4.07M	0.0%	+4.2%	2.192%
6/17/2021	Geneos Wealth Management Inc.	511,606	$2.26M	0.1%	+5.4%	0.881%
5/19/2021	Virtu Financial LLC	14,683	$32K	0.0%	N/A	0.026%
5/18/2021	D. E. Shaw & Co. Inc.	45,775	$99K	0.0%	-10.8%	0.080%
5/18/2021	Morgan Stanley	26,360	$57K	0.0%	-50.9%	0.046%
5/17/2021	Vivaldi Capital Management LLC	10,668	$45K	0.0%	-30.9%	0.019%
5/17/2021	Nuveen Asset Management LLC	177,035	$0.38M	0.0%	-4.2%	0.310%
5/14/2021	Occudo Quantitative Strategies LP	18,967	$41K	0.0%	N/A	0.033%
5/14/2021	Dimensional Fund Advisors LP	11,977	$26K	0.0%	N/A	0.021%
5/13/2021	Barclays PLC	31,094	$68K	0.0%	+159.0%	0.054%
5/13/2021	Renaissance Technologies LLC	307,000	$0.67M	0.0%	+1,864.5%	0.537%
5/13/2021	Neuberger Berman Group LLC	13,614	$30K	0.0%	-25.2%	0.024%
5/13/2021	Bank of New York Mellon Corp	99,901	$0.22M	0.0%	-7.0%	0.175%
5/13/2021	Bank of Montreal Can	21,329	$53K	0.0%	+272.7%	0.037%
5/12/2021	Northern Trust Corp	421,103	$0.91M	0.0%	-7.0%	0.737%
5/12/2021	Geode Capital Management LLC	645,867	$1.40M	0.0%	+0.6%	1.130%
5/12/2021	JPMorgan Chase & Co.	100,555	$0.22M	0.0%	-3.0%	0.176%
5/7/2021	BlackRock Inc.	2,620,626	$5.69M	0.0%	+0.9%	4.585%
5/7/2021	D.A. Davidson & CO.	65,310	$0.14M	0.0%	-91.5%	0.114%
4/26/2021	Wedbush Securities Inc.	17,998	$39K	0.0%	-12.2%	0.031%
3/2/2021	FormulaFolio Investments LLC	12,710	$28K	0.0%	N/A	0.022%
2/19/2021	JPMorgan Chase & Co.	103,713	$0.23M	0.0%	+378.5%	0.182%
2/12/2021	Raymond James Financial Services Advisors Inc.	18,229	$41K	0.0%	N/A	0.032%
2/11/2021	Northern Trust Corp	452,957	$1.01M	0.0%	-2.8%	0.794%
2/11/2021	Barclays PLC	12,006	$27K	0.0%	-30.5%	0.021%
2/10/2021	Renaissance Technologies LLC	15,627	$35K	0.0%	N/A	0.027%
2/10/2021	D.A. Davidson & CO.	767,321	$1.72M	0.0%	-10.1%	1.344%
2/9/2021	Wells Fargo & Company MN	96,815	$0.22M	0.0%	+69.1%	0.170%
2/5/2021	BlackRock Inc.	2,598,089	$5.82M	0.0%	+3.8%	4.552%
2/4/2021	Cambridge Investment Research Advisors Inc.	179,556	$0.40M	0.0%	-6.1%	0.315%
11/13/2020	Morgan Stanley	31,579	$85K	0.0%	-51.6%	0.055%
11/12/2020	JPMorgan Chase & Co.	21,674	$72K	0.0%	-22.6%	0.038%
11/10/2020	State Street Corp	698,113	$1.86M	0.0%	+1.5%	1.223%
11/9/2020	The Manufacturers Life Insurance Company	26,819	$72K	0.0%	+23.4%	0.047%
11/9/2020	LPL Financial LLC	18,584	$50K	0.0%	-34.2%	0.033%
11/6/2020	BlackRock Inc.	2,503,111	$6.68M	0.0%	-0.4%	4.385%
10/29/2020	Cambridge Investment Research Advisors Inc.	191,195	$0.51M	0.0%	-5.8%	0.335%
10/13/2020	Brookstone Capital Management	12,710	$34K	0.0%	N/A	0.022%
9/15/2020	Two Sigma Advisers LP	11,800	$36K	0.0%	N/A	0.021%
8/25/2020	Nuveen Asset Management LLC	181,943	$0.56M	0.0%	+39.9%	0.319%
8/14/2020	Bank of America Corp DE	10,895	$33K	0.0%	+145.8%	0.019%
8/14/2020	Advisor Group Holdings Inc.	1,012,430	$3.10M	0.0%	+17.1%	1.775%
8/13/2020	Vivaldi Capital Management LLC	15,439	$40K	0.0%	+44.7%	0.027%
8/12/2020	Goldman Sachs Group Inc.	20,794	$64K	0.0%	+24.7%	0.036%
7/31/2020	UBS Group AG	12,401	$38K	0.0%	-50.4%	0.022%
6/19/2020	State Street Corp	663,783	$1.30M	0.0%	-1.1%	1.164%
5/18/2020	Advisor Group Holdings Inc.	864,275	$1.69M	0.0%	N/A	1.515%
5/15/2020	Morgan Stanley	55,511	$0.11M	0.0%	-66.1%	0.097%
5/15/2020	Two Sigma Investments LP	16,932	$33K	0.0%	N/A	0.030%
5/14/2020	Wells Fargo & Company MN	45,658	$89K	0.0%	+45.1%	0.080%
5/14/2020	Geode Capital Management LLC	561,368	$1.10M	0.0%	+3.1%	0.984%
5/14/2020	Deutsche Bank AG	13,826	$28K	0.0%	-35.1%	0.024%
5/14/2020	MML Investors Services LLC	28,541	$56K	0.0%	+28.9%	0.050%
5/14/2020	Nuveen Asset Management LLC	130,022	$0.26M	0.0%	+21.2%	0.228%
5/12/2020	JPMorgan Chase & Co.	40,599	$79K	0.0%	+209.2%	0.071%
5/11/2020	State Street Corp	663,783	$1.30M	0.0%	-1.1%	1.164%

Data available starting January 2016

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Today's Range

Now: $2.01

$1.91

$2.02

50 Day Range

MA: $2.36

$1.93

$3.01

52 Week Range

Now: $2.01

$1.82

$5.70

Volume

115,402 shs

Average Volume

126,984 shs

Market Capitalization

$119.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.94

Who are the company insiders with the largest holdings of Galectin Therapeutics?: Galectin Therapeutics' top insider investors include:
Gilbert F Amelio (Director)
Kevin D Freeman (Director)
Fund LP 10X (Major Shareholder)
Richard A Jr Zordani (Director)

5 Free Dividend Stocks for 2022

From Motley Fool | Ad

Could these top payout stocks be part of the greatest wealth-creating tool in history?

Learn More.